✦ LIBER ✦

Adjuvant Therapy of Breast Cancer with Pirarubicin Versus Epirubicin in Combination with Cyclophosphamide and 5-fluorouracil

✍ Scribed by Jun-Jie Li; Gen-Hong Di; Li-Chen Tang; Ke-Da Yu; Zhen Hu; Guang-Yu Liu; Jing-Song Lu; Jiong Wu; Qi-Xia Han; Zhen-Zhou Shen; Zhi-Ming Shao

Book ID: 109080231
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 100 KB
Volume: 17
Category: Article
ISSN: 1075-122X
DOI: 10.1111/j.1524-4741.2011.01158.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P87 Adjuvant therapy of primary breast c

P87 Adjuvant therapy of primary breast cancer with doxorubicin vs. pirarubicin in combination with cyclophosphamide and 5-fluorouracil (FAC vs. FPC)

✍ Z. Budišic; P. Podolski; L. Markulin-Grgić; F. Šantek; E. Kosovel 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 295 KB

Prospective randomized study of cyclopho

Prospective randomized study of cyclophosphamide, epirubicin, and 5-fluorouracil versus cyclophosphamide, adriamycin, and 5-fluorouracil in advanced or recurrent breast cancer

✍ Tetsuro Kobayashi; Hiroki Koyama; Takahiro Oka; Tadaki Yasumura; Norimichi Kan; 📂 Article 📅 1999 🏛 Springer Japan 🌐 English ⚖ 475 KB

Phase III trial of cyclophosphamide, epi

Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer

✍ E. Esteban; A.J. Lacave; J.L. Fernández; N. Corral; J.M. Buesa; E. Estrada; I. P 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 68 KB

Phase I trial of adjuvant chemotherapy w

Phase I trial of adjuvant chemotherapy with cyclophosphamide, epirubicin and 5-fluorouracil (CEF) for stage II breast cancer

✍ Stephen E. Jones; Robert G. Mennel; George N. Peters; Mary Alice Westrick; Barry 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 263 KB

Epirubicin is a new anthracycline with a potentially more favorable toxicity profile than the parent compound, doxorubicin. Accordingly, the feasibility and toxicity of 6 courses of adjuvant chemotherapy with cyclophosphamide (C), epirubicin (E), and 5-fluorouracil (F) were assessed in 10 patients w

Risk of venous thromboembolism in patien

Risk of venous thromboembolism in patients receiving adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide for early breast cancer

✍ Julia HOY; Teresa NEEMAN; Robin STUART-HARRIS; Alison DAVIS 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

383 Comparative study: Pirarubicin vs do

383 Comparative study: Pirarubicin vs doxorubicin in combination with cyclophosphamide and fluorouracil in the treatment of breast cancer

✍ Z. Budišić; H. Predrijevac; P. Podolski; M. Gošev 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 291 KB